Although the pathogenesis of sporadic Alzheimer disease (AD) is not clearly understood, it is likely dependent on several age-related factors. Diabetes is a risk factor for AD, and multiple mechanisms connecting the 2 diseases have been proposed. Hyperglycemia enhances the formation of advanced glycation end products (AGEs) that result from the auto-oxidation of glucose and fructose. The interaction of AGEs with their receptor, named RAGE, elicits the formation of reactive oxygen species that are also believed to be an early event in AD pathology. To investigate a functional link between the disorders diabetes and AD, the effect of 2 AGEs, pentosidine and glyceraldehydes-derived pyridinium (GLAP), was studied on BACE1 expression both in vivo, in streptozotocin treated rats, and in vitro in differentiated neuroblastoma cells. We showed that pentosidine and GLAP were able to upregulate BACE1 expression through their binding with RAGE and the consequent activation of NF-kappaB. In addition, both pentosidine and GLAP were found to be increased in the brain in sporadic AD patients. Our findings demonstrate that activation of the AGEs/RAGE axis, by upregulating the key enzyme for amyloid-beta production, provides a pathologic link between diabetes mellitus and AD.

AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation

GUGLIELMOTTO, Michela;ARAGNO, Manuela;TAMAGNO, Elena;VERCELLINATTO, Ilenia;VISENTIN, Sonia;MEDANA, Claudio;CATALANO, Maria Graziella;DANNI, Oliviero;BOCCUZZI, Giuseppe;
2012-01-01

Abstract

Although the pathogenesis of sporadic Alzheimer disease (AD) is not clearly understood, it is likely dependent on several age-related factors. Diabetes is a risk factor for AD, and multiple mechanisms connecting the 2 diseases have been proposed. Hyperglycemia enhances the formation of advanced glycation end products (AGEs) that result from the auto-oxidation of glucose and fructose. The interaction of AGEs with their receptor, named RAGE, elicits the formation of reactive oxygen species that are also believed to be an early event in AD pathology. To investigate a functional link between the disorders diabetes and AD, the effect of 2 AGEs, pentosidine and glyceraldehydes-derived pyridinium (GLAP), was studied on BACE1 expression both in vivo, in streptozotocin treated rats, and in vitro in differentiated neuroblastoma cells. We showed that pentosidine and GLAP were able to upregulate BACE1 expression through their binding with RAGE and the consequent activation of NF-kappaB. In addition, both pentosidine and GLAP were found to be increased in the brain in sporadic AD patients. Our findings demonstrate that activation of the AGEs/RAGE axis, by upregulating the key enzyme for amyloid-beta production, provides a pathologic link between diabetes mellitus and AD.
2012
33
1
13
27
Guglielmotto M; Aragno M; Tamagno E; Vercellinatto I; Visentin S; Medana C; Catalano MG; Smith MA; Perry G; Danni O; Boccuzzi G; Tabaton M.
File in questo prodotto:
File Dimensione Formato  
neurobiol aging 2010.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 1.67 MB
Formato Adobe PDF
1.67 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/81738
Citazioni
  • ???jsp.display-item.citation.pmc??? 56
  • Scopus 134
  • ???jsp.display-item.citation.isi??? 123
social impact